Skip to content
Menu

Kestra Medical Technologies, Ltd. KMTS

Full chart Compare
Set alert

Price alert · KMTS

All alert types
26.63 USD -1.66 (-5.87%)

Regular-session close

26.63 0.00 0.00%

After hours · Nov 19, 4:01 PM ET

26.34 Day range 28.48
17.34 52-week range 31.99
YTD
+0.41%
1 year
+3.10%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 31.13 +16.9% upside
Target (low)
28.00
Target (mean)
31.13
Target (high)
34.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy6
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 9
  • 2 months ago 8
  • 3 months ago 8

Included in Essentials and up

Sign in to see Revenue and earnings forecast

Reported revenue and earnings per share by year, then what analysts expect next.

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

KMTS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.605-0.61 – -0.60-0.4493-34.6%32.09M+42.2%2
Next quarter-0.575-0.58 – -0.57-0.4042-42.3%35.49M+44.5%2
Current year-2.45-2.46 – -2.44-1.71-43.4%140.85M+48.1%2
Next year-2.06-2.06 – -2.05-2.45+16.1%195.99M+39.2%2

Upgrades and downgrades

The latest rating changes

KMTS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 20, 2026Evercore ISI GroupInitiated—Outperform
Sep 15, 2026BTIGReiteratedBuyBuy
Sep 2, 2026BTIGReiteratedBuyBuy
Aug 10, 2026JP MorganInitiated—Overweight
Jul 21, 2026OppenheimerInitiated—Perform
Jul 15, 2026BTIGMaintainedBuyBuy
Apr 9, 2026Goldman SachsMaintainedNeutralNeutral
Apr 7, 2026BTIGReiteratedBuyBuy
Mar 25, 2026BTIGReiteratedBuyBuy
Mar 18, 2026BTIGReiteratedBuyBuy
Dec 15, 2025Goldman SachsMaintainedNeutralNeutral
Dec 12, 2025Wells FargoMaintainedOverweightOverweight
Dec 12, 2025Piper SandlerMaintainedOverweightOverweight
Nov 18, 2025BTIGInitiated—Buy
Jul 17, 2025Wells FargoMaintainedOverweightOverweight
Apr 16, 2025Goldman SachsMaintainedNeutralNeutral
Mar 31, 2025Wolfe ResearchInitiated—Outperform
Mar 31, 2025Wells FargoInitiated—Overweight
Mar 31, 2025StifelInitiated—Buy
Mar 31, 2025Goldman SachsInitiated—Neutral
Mar 31, 2025Piper SandlerInitiated—Overweight

Included in Plus and up

Sign in to see Analyst trend

Two years of the analyst rating mix and the average price target against the price.